Erythromycin Estolate for Oral Suspension
»Erythromycin Estolate for Oral Suspension is a dry mixture of Erythromycin Estolate with one or more suitable buffers,colors,diluents,dispersants,and flavors.It contains the equivalent of not less than 90.0percent and not more than 115.0percent of the labeled amount of erythromycin (C37H67NO13).
Packaging and storage— Preserve in tight containers.
Identification— Prepare a test solution by mixing a quantity of Erythromycin Estolate for Oral Suspension with methanol to obtain a concentration equivalent to about 20mg of erythromycin per mL.Prepare a Standard solution of USP Erythromycin Estolate RSin methanol containing the equivalent of 20mg of erythromycin per mL.Apply separately 3µLof each solution to a thin-layer chromatographic plate (see Chromatography á621ñ)coated with a 0.25-mm layer of chromatographic silica gel.Proceed as directed in the Identificationtest under Erythromycin Delayed-Release Capsules,beginning with “Place the plate in an unlined chromatographic chamber.”
Uniformity of dosage units á905ñ
FORSOLID PACKAGED IN SINGLE-UNIT CONTAINERS :meets the requirements.
Deliverable volume á698ñ: meets the requirements.
pHá791ñ: between 5.0and 7.0(if pediatric drops,between 5.0and 5.5),in the suspension constituted as directed in the labeling.
Water,Method Iá921ñ: not more than 2.0%,20mLof methanol containing 10%of imidazole being used in place of methanol in the titration vessel.
Assay— Constitute Erythromycin Estolate for Oral Suspension as directed in the labeling,and proceed as directed in the Assayunder Erythromycin Estolate Oral Suspension.
Auxiliary Information— Staff Liaison:William W.Wright,Ph.D.,Scientific Fellow
Expert Committee:(PA7)Pharmaceutical Analysis 7
USP28–NF23Page 764
Phone Number:1-301-816-8335